These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3297176)

  • 1. Clinical predictors of response to antidepressants in elderly patients.
    Georgotas A; McCue RE; Cooper T; Chang I; Mir P; Welkowitz J
    Biol Psychiatry; 1987 Jun; 22(6):733-40. PubMed ID: 3297176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting the delay of antidepressant effect in responders to nortriptyline and phenelzine.
    Georgotas A; McCue RE; Cooper TB; Nagachandran N; Friedhoff A
    Psychiatry Res; 1989 Apr; 28(1):1-9. PubMed ID: 2662234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of depressive symptoms to nortriptyline, phenelzine and placebo.
    Georgotas A; McCue RE; Friedman E; Cooper TB
    Br J Psychiatry; 1987 Jul; 151():102-6. PubMed ID: 3676606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A placebo-controlled comparison of the effect of nortriptyline and phenelzine on orthostatic hypotension in elderly depressed patients.
    Georgotas A; McCue RE; Friedman E; Cooper TB
    J Clin Psychopharmacol; 1987 Dec; 7(6):413-6. PubMed ID: 3323263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients.
    Georgotas A; McCue RE; Cooper TB
    Arch Gen Psychiatry; 1989 Sep; 46(9):783-6. PubMed ID: 2673129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The usefulness of DST in predicting response to antidepressants: a placebo-controlled study.
    Georgotas A; Stokes P; McCue RE; Dubow A; Welkowitz J; Friedman E; Fanelli C; Chang I; Cooper TB
    J Affect Disord; 1986; 11(1):21-8. PubMed ID: 2944924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy and safety of MAOIs versus TCAs in treating depression in the elderly.
    Georgotas A; McCue RE; Hapworth W; Friedman E; Kim OM; Welkowitz J; Chang I; Cooper TB
    Biol Psychiatry; 1986 Oct; 21(12):1155-66. PubMed ID: 3756264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to phenelzine and amitriptyline in subtypes of outpatient depression.
    Paykel ES; Rowan PR; Parker RR; Bhat AV
    Arch Gen Psychiatry; 1982 Sep; 39(9):1041-9. PubMed ID: 7052009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrocardiographic effects of nortriptyline, phenelzine, and placebo under optimal treatment conditions.
    Georgotas A; McCue RE; Friedman E; Cooper TB
    Am J Psychiatry; 1987 Jun; 144(6):798-801. PubMed ID: 3592003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of DMS-III depressive subtype and chronicity of antidepressant efficacy in atypical depression. Differential response to phenelzine, imipramine, and placebo.
    Stewart JW; McGrath PJ; Quitkin FM; Harrison W; Markowitz J; Wager S; Leibowitz MR
    Arch Gen Psychiatry; 1989 Dec; 46(12):1080-7. PubMed ID: 2686575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of response to nortriptyline and phenelzine by platelet MAO activity.
    Georgotas A; McCue RE; Friedman E; Cooper T
    Am J Psychiatry; 1987 Mar; 144(3):338-40. PubMed ID: 3826434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenelzine and amitriptyline: effects on symptoms of neurotic depression.
    Rowan PR; Paykel ES; Parker RR
    Br J Psychiatry; 1982 May; 140():475-83. PubMed ID: 7049292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenelzine for chronic depression: a study of continuation treatment.
    Harrison W; Rabkin J; Stewart JW; McGrath PJ; Tricamo E; Quitkin F
    J Clin Psychiatry; 1986 Jul; 47(7):346-9. PubMed ID: 3522558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How effective and safe is continuation therapy in elderly depressed patients? Factors affecting relapse rate.
    Georgotas A; McCue RE; Cooper TB; Nagachandran N; Chang I
    Arch Gen Psychiatry; 1988 Oct; 45(10):929-32. PubMed ID: 3421805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline.
    Uher R; Dernovsek MZ; Mors O; Hauser J; Souery D; Zobel A; Maier W; Henigsberg N; Kalember P; Rietschel M; Placentino A; Mendlewicz J; Aitchison KJ; McGuffin P; Farmer A
    J Affect Disord; 2011 Jul; 132(1-2):112-20. PubMed ID: 21411156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relapse of depressed patients after effective continuation therapy.
    Georgotas A; McCue RE
    J Affect Disord; 1989; 17(2):159-64. PubMed ID: 2527891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychopharmacologic validation of atypical depression.
    Liebowitz MR; Quitkin FM; Stewart JW; McGrath PJ; Harrison W; Rabkin JG; Tricamo E; Markowitz JS; Klein DF
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):22-5. PubMed ID: 6376483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo.
    Quitkin FM; Stewart JW; McGrath PJ; Tricamo E; Rabkin JG; Ocepek-Welikson K; Nunes E; Harrison W; Klein DF
    Br J Psychiatry Suppl; 1993 Sep; (21):30-4. PubMed ID: 8217065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial.
    Jarrett RB; Schaffer M; McIntire D; Witt-Browder A; Kraft D; Risser RC
    Arch Gen Psychiatry; 1999 May; 56(5):431-7. PubMed ID: 10232298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tranylcypromine vs nortriptyline vs placebo in depressed outpatients: a controlled trial.
    White K; Razani J; Cadow B; Gelfand R; Palmer R; Simpson G; Sloane RB
    Psychopharmacology (Berl); 1984; 82(3):258-62. PubMed ID: 6425910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.